| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $162.3M | -11.1% | -6.3% |
| Cost of Revenue | $127.4M | -8.7% | -4.3% |
| Gross Profit | $34.8M | -18.7% | -13.0% |
| R&D Expense | $25.2M | +4.4% | +5.2% |
| SG&A Expense | $23.2M | -0.4% | +5.6% |
| Operating Income | -$13.6M | -195.9% | -129.6% |
| Pre-tax Income | -$11.7M | -638.7% | -143.2% |
| Income Tax | $1.5M | -22.7% | +20.0% |
| Net Income | -$13.3M | -526.4% | -101.0% |
| EPS (Basic) | -$0.45 | -542.9% | -95.7% |
| EPS (Diluted) | -$0.45 | -542.9% | -95.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $196.3M | -12.2% | +7.5% |
| Accounts Receivable | $29.0M | -21.8% | +46.0% |
| Inventory | $200.1M | +2.0% | +8.9% |
| Current Assets | $482.4M | -9.2% | +17.6% |
| Total Assets | $1.00B | -3.4% | -11.6% |
| Current Liabilities | $140.2M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.1M | -79.8% | — |
| Capital Expenditures | $24.7M | +153.2% | — |
| Investing Cash Flow | $74.5M | -9.1% | — |
| Financing Cash Flow | -$33.2M | -53.5% | — |
| Free Cash Flow | -$22.7M | -5497.1% | — |
| -7.1% |
| Long-term Debt | $2.1M | -26.6% | -89.9% |
| Total Liabilities | $183.5M | -9.8% | -20.7% |
| Stockholders' Equity | $818.8M | -1.8% | -9.3% |